May 1, 2024 Inflation Persistence: No Fed Rate Cuts in Sight
April 29, 2024 Tesla, Baidu Join Forces for Self-Driving Tech in China
Apple: Time For A Rebrand
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
April 12, 2024 Improve Your Financial Status: A How-To Guide
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
Context Therapeutics (CNTX) dividend
When will Context Therapeutics pay the next dividends?
The date of payment of the next dividends from the Context Therapeutics is scheduled for N/A.
If you see an old date, it means that the company has not yet approved a new dividend payout date. As soon as they do, we will update the information immediately. Bookmark our site to stay informed.
Context Therapeutics dividend per share:
Dividends are paid at $ None per share.
Context Therapeutics dividend history:
Previous date of dividend payment: N/A.
Splitting upContext Therapeutics shares:
No information concerning Context Therapeutics splitting shares.
Last Split Factor: N/A
Context Therapeutics stock forecast.
What will happen to Context Therapeutics stock? Context Therapeutics shares will rise or fall. Visit the prediction section of our website to get an answer to this question.
Sell or Buy Context Therapeutics (CNTX) stocks? Analytic Experts Forecasting...
Context Therapeutics stock chart in real time
A real-time chart of the Context Therapeutics stock price is shown below. By default, the chart is set to the daily timeframe, but you can change it to the one that interests you. You can also use indicators on the chart.
Context Therapeutics information and performance
Context Therapeutics Address
2001 MARKET STREET, SUITE 3915 UNIT #15, PHILADELPHIA, PA, US
Market Capitalization: 28 419 700 $
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA: -25 060 572 $
EBITDA is earnings before interest, income tax and depreciation of assets.
PE Ratio: None
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio: None
Price/earnings to growth
DPS: None
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
DY: None
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS: -1.5
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY: 0
Quarterly Revenue Growth YOY: 0
Trailing PE: -
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE: -
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue: -
Enterprise Value (EV) /Revenue
EV To EBITDA: 0.0535
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding: 15966100
Number of issued ordinary shares
Shares Float:
Number of freely tradable shares
Shares Short Prior Month:
Shares Short Prior Month - the number of shares in short positions in the last month.
Short Ratio:
Percent Insiders:
Percent Institutions: